TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05412628

Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Oral swab test
Description: In this study, we will perform tissue biopsy at esophageal tumor site in esophageal cancer patients and perform random biopsy at middle esophagus in patients without esophageal cancer. Besides, we will take oral swab in all participants.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Oral swab test
Description: In this study, we will perform tissue biopsy at esophageal tumor site in esophageal cancer patients and perform random biopsy at middle esophagus in patients without esophageal cancer. Besides, we will take oral swab in all participants.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Oral swab test
Description: In this study, we will perform tissue biopsy at esophageal tumor site in esophageal cancer patients and perform random biopsy at middle esophagus in patients without esophageal cancer. Besides, we will take oral swab in all participants.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Oral swab test
Description: In this study, we will perform tissue biopsy at esophageal tumor site in esophageal cancer patients and perform random biopsy at middle esophagus in patients without esophageal cancer. Besides, we will take oral swab in all participants.
Study: NCT05359601

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Infusion set replacement intervals
Description: 24-hour or 96-hour infusion set replacement intervals

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Infusion set replacement intervals
Description: 24-hour or 96-hour infusion set replacement intervals
Study: NCT06663189

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Quality of Life questionnaires
Description: EQ-5D5L: EuroQol-5-Dimension 5 levels Burden of Treatment Questionnaire (BTQ self-administered questionnaires) Hospital Anxiety and Depression (HAD) questionnaire

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Disability evaluation tests
Description: EDSS: Expanded Disability Status Scale 25Foot/Walk 9-HPT:Nine Hole Peg Test

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Disability evaluation tests
Description: EDSS: Expanded Disability Status Scale 25Foot/Walk 9-HPT:Nine Hole Peg Test
Study: NCT05784558

Intervention type: DEVICE
Intervention: UroLift System
Description: The UroLift System is a procedure that utilizes tiny implants to lift and hold the enlarged prostate tissue out of the way so it no longer blocks the urethra.

Intervention type: OTHER
Intervention: Watchful Waiting or BPH Medications
Description: Subjects for whom the physician decides the best course of therapy to be either watchful waiting or new or continuing BPH medications.

Intervention type: DEVICE
Intervention: Other Surgical Intervention
Description: Physician decides the best course of therapy to be a surgical intervention other than the UroLift System.
Study: NCT05296993

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Extracts found in the Extended Longevity supplements
Description: Ingredients found in these serums are all naturally occurring, and extracted from a variety of plant species.
Study: NCT06372496

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
Description: Participants will receive FF/UMEC/VI

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Inhaled corticosteroids/long-acting beta-2 agonists
Description: Participants will receive ICS/LABA
Study: NCT04797871

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance training
Description: Participants will complete a 2-days-a-week training routine: Resistance training (RT, 50-75% 1RM (one-repetition maximum), 4 sets, 8-12 repetitions, 4 exercises). The warn up include Light Intensity Continuous Training (8-10 min, 65-70% HRR). Progressions will be individualized and consistent with patient tolerance. Sessions will be supervised by Physiotherapists and Graduated in Sports Sciences.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: This group will be allocated to standard care and therefore no supervised exercise regimen according to scientific guidelines for general physical activity and return to sport provided by the ACSM guidelines for Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.
Study: NCT05623358

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacist-led HFrEF medication optimization
Description: In addition to usual care, participants randomized to the intervention arm will receive co-management of medications by a clinical pharmacist with advanced training and expanded scope of practice, with the aim of achieving optimal medical therapy (OMT) for HFrEF as outlined by the 2021 Canadian Cardiovascular Society (CCS) HF guidelines. This will consist of, where possible, the combination of an angiotensin receptor-neprilysin inhibitor (ARNI), evidence-based beta-blocker, mineralocorticoid receptor antagonist (MRA), and sodium-glucose cotransporter 2 inhibitor (SGLT2i) at target doses, along with personalized therapies as outlined in the 2021 CCS HF guidelines, unless the patient is unable to tolerate these agents/doses.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Both the intervention group and comparator group will receive usual care by the multidisciplinary HF clinic, including standard-of-care clinical pharmacy services. The standard pathway in the HF clinic consists of an initial consultation with the multidisciplinary team (cardiologist, physician trainees, registered nurse and clinical pharmacist), follow-up visits approximately every 3 months with the nurse and cardiologist until discharge, along with telehealth nurse calls for medication titrations.

Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: Both the intervention group and comparator group will receive usual care by the multidisciplinary HF clinic, including standard-of-care clinical pharmacy services. The standard pathway in the HF clinic consists of an initial consultation with the multidisciplinary team (cardiologist, physician trainees, registered nurse and clinical pharmacist), follow-up visits approximately every 3 months with the nurse and cardiologist until discharge, along with telehealth nurse calls for medication titrations.
Study: NCT06526910

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Swallowing exercises
Description: Standard-of-care swallowing exercises include tongue exercise. The experimental part added in Phase 3 includes some participants completed standard-of-care exercises again and others completing standard-of-care exercises and motor imagery practice of those exercises.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Swallowing exercises
Description: Standard-of-care swallowing exercises include tongue exercise. The experimental part added in Phase 3 includes some participants completed standard-of-care exercises again and others completing standard-of-care exercises and motor imagery practice of those exercises.
Study: NCT06141759

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Cheneau brace and Schroth Best Practice exercise
Study: NCT06197763

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colesevelam
Description: 625 mg tablets - 3 tables twice per day of Colesevelam or placebo for 6 weeks (crossover), interspersed by 8 week of washout time.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control Arm
Description: No Treatment: baseline assessment only
Study: NCT04716101

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Massage therapy technique
Description: The massage therapy technique consists of manual deep and slow compression and shearing forces applied on the lumbar spine muscles and thoracolumbar fascia in a distal to proximal direction.
Study: NCT05029986

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Socialization phase
Description: Control condition: does not involve speech-related exercises

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Speech breathing intervention
Description: Experimental condition: involves speech-related exercises
Study: NCT00643422

Intervention type: DEVICE
Intervention: Cirrus™ HD-OCT, Carl Zeiss Meditec AG
Description: the retinal thickness and volume is determined on two different days with the Cirrus™ HD-OCT.
Study: NCT04716101

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage therapy technique
Description: The massage therapy technique consists of manual deep and slow compression and shearing forces applied on the lumbar spine muscles and thoracolumbar fascia in a distal to proximal direction.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sham massage technique
Description: For the sham massage technique the massage therapist will put the right palm at the participant's right lower back along erector spinae and likewise left palm at left lower back without applying force, holding the palm during 2 minutes and half.
Study: NCT05577676

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound-guided Hydrodissection of the Median Nerve
Description: Hydrodissection for CTS includes injecting fluid around the median nerve (MN) with 5 ml volume, 3 ml of which is given in between the transverse carpal ligament \& MN, and 2 ml below the MN under Ultrasound guidance in-plane ulnar approach.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Hydrodissection of the Median Nerve
Description: Hydrodissection for CTS includes injecting fluid around the median nerve (MN) with 5 ml volume, 3 ml of which is given in between the transverse carpal ligament \& MN, and 2 ml below the MN under Ultrasound guidance in-plane ulnar approach.
Study: NCT05831956

Intervention type: PROCEDURE
Intervention: Laparoscopic colectomy
Description: Patients who under went laparoscopic colectomy
Study: NCT06074913

Intervention type: OTHER
Group type: OTHER
Intervention: infrared thermography (IRT)
Description: Temperatures and infrared thermograms were recorded in the region of the extremities of three groups of subjects by using an infrared thermographic camera.

Intervention type: OTHER
Group type: OTHER
Intervention: infrared thermography (IRT)
Description: Temperatures and infrared thermograms were recorded in the region of the extremities of three groups of subjects by using an infrared thermographic camera.

Intervention type: OTHER
Group type: OTHER
Intervention: infrared thermography (IRT)
Description: Temperatures and infrared thermograms were recorded in the region of the extremities of three groups of subjects by using an infrared thermographic camera.
Study: NCT04716101

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sham massage technique
Description: For the sham massage technique the massage therapist will put the right palm at the participant's right lower back along erector spinae and likewise left palm at left lower back without applying force, holding the palm during 2 minutes and half.
Study: NCT06074913

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Basal therapy+EA
Description: After specialist treatment, blood glucose is managed through hypoglycemic medications or insulin. Patients with both hypertension and hyperlipidemia are prescribed antihypertensive and lipid-lowering drugs. Additional medications are determined based on the patient's current medication regimen. 2. Acupoints: Qihai (RN6), Guanyuan (RN4), Xuehai (SP10), Yanglingquan (GB34), Zusanli (T36), Yinlingquan (SP9), Sanyinjiao (SP6), Xuanzhong (GB39), Jiexi (ST41), Zulinqi (GB41), Taichong (SP41). The electrode will be connected Yanglingquan (GB34) and Sanyinjiao (SP6), electrode wire will be connected to the electro-acupuncture apparatus using continuous wave with a frequency of 2Hz at an intensity suitable for the comfort of the subject.

Intervention type: OTHER
Group type: OTHER
Intervention: Basal therapy
Description: After specialist treatment, blood glucose is managed through hypoglycemic medications or insulin. Patients with both hypertension and hyperlipidemia are prescribed antihypertensive and lipid-lowering drugs. Additional medications are determined based on the patient's current medication regimen.
Study: NCT06308809

Intervention type: OTHER
Group type: OTHER
Intervention: PNF training
Description: The subjects underwent rehabilitation training for 8 weeks, three times a week (Monday, Wednesday and Friday, 6:00 PM to 10:00 PM in the Physical Education College of Guangxi Normal University), and the rehabilitation training time was about 40-45 minutes per person. Before each rehabilitation training, the subjects warmed up the ankle and lower leg muscles for 5 minutes, followed by the corresponding rehabilitation training for 30-35 minutes, and relaxed the ankle and lower leg muscles for 5 minutes after the training.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNF training
Description: The subjects underwent rehabilitation training for 8 weeks, three times a week (Monday, Wednesday and Friday, 6:00 PM to 10:00 PM in the Physical Education College of Guangxi Normal University), and the rehabilitation training time was about 40-45 minutes per person. Before each rehabilitation training, the subjects warmed up the ankle and lower leg muscles for 5 minutes, followed by the corresponding rehabilitation training for 30-35 minutes, and relaxed the ankle and lower leg muscles for 5 minutes after the training.
Study: NCT05755659

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fosaprepitant Dimeglumine for Injection
Description: The specification of Fosaprepitant Dimeglumine for injection is 150 mg, and the usage and dosage is: when preventing nausea and vomiting caused by HEC, this product is used in combination with dexamethasone and 5-HT3 antagonist. The dosage of Fosaprepitant Dimeglumine for injection is 150 mg, and the infusion time is 20-30 minutes. The intravenous infusion is completed 30 minutes before the beginning of chemotherapy on the first day.
Study: NCT05934864

Intervention type: GENETIC
Intervention: 84-gene penal
Description: 84-gene penal was targeted sequenced in 1000 PTCL patients to investigate their mutation profile and molecular subtypes.
Study: NCT06124794

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PROTOXIN
Description: Clostridium botulinum toxin type A
Study: NCT04908553

Intervention type: DRUG
Group type: OTHER
Intervention: Remimazolam Tosilate for Injection 0.1mg/kg
Description: Remimazolam Tosilate for Injection 0.1mg/kg at induction

Intervention type: DRUG
Group type: OTHER
Intervention: Remimazolam Tosilate for Injection 0.15mg/kg
Description: Remimazolam Tosilate for Injection 0.15mg/kg at induction

Intervention type: DRUG
Group type: OTHER
Intervention: Remimazolam Tosilate for Injection 0.2mg/kg
Description: Remimazolam Tosilate for Injection 0.2mg/kg at induction
Study: NCT06267664

Intervention type: DRUG
Intervention: Patients with migraine treated with triptans, Lasmiditan or Gepants
Description: Patients will complete the study information in their smartphones, tablets or computers, using a QR code or a link that will redirect hem to the study questionnaires. RedCap will be used in the study.
Study: NCT04699461

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Loncastuximab Tesirine
Description: IV infusion

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Idelalisib
Description: Oral tablet
Study: NCT05023278

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venlafaxine 37.5 MG
Description: venlafaxine 37.5mg daily for 7 consecutive days.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo filled pill daily for 7 consecutive days.
Study: NCT05261009

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peri-capsular Nerve Group (PENG)
Description: PENG block for postoperative pain management

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lumbar Plexus Block (LPB)
Description: LPB for postoperative pain management
Study: NCT05476029

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood samples and alveolar lavage fluid were collected
Description: Blood samples and alveolar lavage fluid were collected for exosome sorting and identification, differential miRNAs, and analysis of serum oxidation and inflammatory indicators.

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood samples and alveolar lavage fluid were collected
Description: Blood samples and alveolar lavage fluid were collected for exosome sorting and identification, differential miRNAs, and analysis of serum oxidation and inflammatory indicators.
Study: NCT05928494

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scenario-based high-fidelity simulation method
Description: Postpartum care applications were carried out with the high-reality Gaumard Scientific brand, product code: S550.100 Noella simulator in the simulation laboratory of the midwifery department to the students in the intervention group.
Study: NCT06130462

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Aluminum
Description: Different concentrations of aluminium added to the blood test in vitro

Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Tetanus toxoid
Description: Used as control substance
Study: NCT05713435

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intravaginal laser
Description: application of intravaginal laser

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intravaginal laser
Description: application of intravaginal laser

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: intravaginal laser
Description: application of intravaginal laser
Study: NCT04739579

Intervention type: DIAGNOSTIC_TEST
Intervention: C-Reactive Protein
Description: C-Reactive Protein trend in post-operative course

Intervention type: DIAGNOSTIC_TEST
Intervention: C-Reactive Protein
Description: C-Reactive Protein trend in post-operative course
Study: NCT04841772

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Recover Vegan Protein Supplement
Description: Post exercise protein supplement (26g pea protein)

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Post exercise placebo supplement (32g maltodextrin)
Study: NCT05818215

Intervention type: OTHER
Intervention: NO intervention
Description: NO intervention
Study: NCT04335227

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Structured yoga therapy program
Description: Structured yoga therapy prepared according to traditional yoga scriptures of Patanjali yoga sutras will be administered to 32 females with PCOS. The structured yoga therapy which includes, Surya Namaskara (Sun Salutation) and asanas performed in four positions, standing, sitting, supine and prone for total duration of 60 minutes. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program
Description: Thirty two females with PCOS in aerobic exercise (AE) group will be subjected to aerobic training of moderate intensity for 30-60 minutes six days per week for 12 weeks, in the light of guidelines framed by American College of Sports Medicine (ACSM). Aerobic exercise volume for each female recruited will be set at greater than 500 and up to 1000 MET-min/week, which will be approximately equal to 1000 kcal/week. They will be made sure that they exercise for minimum duration of 150 min/week and thereby covering 5400 to 7900 steps/day in pedometer readings. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined yoga and aerobic training program
Description: Thirty two females with PCOS in combined yoga therapy and aerobic exercise (cYTAE) group will be subjected to three days of structured yoga therapy and three days of aerobic training of vigorous intensity. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nutritional management
Description: Thirty two females with PCOS will be asked to undergo only nutritional management uniquely prepared by dietitian
Study: NCT05619939

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein isolate
Description: The indicated protein isolates will be given to subjects as their major protein source

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein isolate
Description: The indicated protein isolates will be given to subjects as their major protein source
Study: NCT06164418

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dental restoration
Description: Each patient will receive a cervical restoration using the corresponding group adhesive and restorative material

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Dental restoration
Description: Each patient will receive a cervical restoration using the corresponding group adhesive and restorative material

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dental restoration
Description: Each patient will receive a cervical restoration using the corresponding group adhesive and restorative material

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Dental restoration
Description: Each patient will receive a cervical restoration using the corresponding group adhesive and restorative material
Study: NCT06353529

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine-Epinephrine 0.5%-1:200,000 Injectable Solution
Description: 2mL injection bilateral (4mL total) of 0.5% bupivacaine with 1:200,000 epinephrine solution, 20G needle, sterile, sphenopalatine ganglion; nerve block

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2mL injection bilateral (4mL total) 0.9% saline solution, 20G needle, sterile, sphenopalatine ganglion; nerve block
Study: NCT05560412

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Zein nanocapsules
Description: 1 g of Zein nanoencapsulated daily

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: control
Description: 1 g of Zein non-encapsulated daily
Study: NCT05528965

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Perpendicular Group
Description: Radiofrequency ablation was applied to the perpendicular group by placing the tip of electrode perpendicularly to contact the genicular nerves.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Parallel Group
Description: Radiofrequency ablation was applied to the parallel group by placing the electrode lay parallel to contact the genicular nerves.
Study: NCT05810324

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-FAPI
Description: Each patient receive a single intravenous injection of 18F-FAPI, and undergo PET/CT scan within specified time.